Results 261 to 270 of about 150,779 (300)
Some of the next articles are maybe not open access.

Inhibition of phospholipid methylation by an anti-allergic agent, NCO-650, during histamine release

Biochemical Pharmacology, 1990
Antigen, anti-IgE and concanavalin A (Con A) induced an increase in both the incorporation of the 3H-methyl moiety into phospholipids and histamine release. Maximal incorporation of the 3H-methyl moiety into the lipid fraction of the cells was observed within 15 sec and 1 min after being challenged with antigen (100 micrograms/mL) and anti-IgE (200 ...
M, Takei   +3 more
openaire   +2 more sources

Modulation of Antigen-Induced Histamine Release from Bovine Granulocytes by Several Anti-Allergic Agents

International Archives of Allergy and Immunology, 1977
Sensitised bovine granulocytes release histamine when exposed to antigen. Several anti-allergic agents, some previously shown to be active in cattle, were tested to investigate their modulation of this histamine release process. Diethylcarbamazine citrate potentiated release at low concentrations and inhibited at high concentrations.
M C, Holroyde, P, Eyre
openaire   +2 more sources

Inhibition of cAMP Increase by an Anti-Allergic Agent, NCO-650, during Histamine Release

International Archives of Allergy and Immunology, 1989
Antigen and concanavalin A (Con A) induced an increase in cAMP and histamine release from rat peritoneal mast cells. In a dose-dependent manner, the compound, NCO-650, significantly inhibited both the initial and secondary increases in cAMP stimulated by antigen, anti-IgE and Con A in rat peritoneal mast cells. IC<sub>50</sub> values of NCO-
M, Takei   +3 more
openaire   +2 more sources

Inhibition of Human Eosinophil Chemotaxis in Vitro by the Anti-Allergic Agent Emedastine Difumarate

Immunopharmacology and Immunotoxicology, 1996
Emedastine difumarate (emedastine), an anti-allergic agent with anti-histaminic properties, was studied for its effect on human eosinophil chemotaxis induced by platelet activating factor (PAF). Peripheral blood eosinophils (98% purity) were obtained from healthy donors and chemotaxis assay were performed in microchemotaxis chambers.
A E, el-Shazly   +4 more
openaire   +2 more sources

Synthesis and biological evaluation of novel laropiprant derivatives as potential anti-allergic agents

Medicinal Chemistry Research, 2015
DP antagonists are claimed to be useful in the treatment of allergic disorders. Laropiprant is a potent and selective DP antagonist to reduce the allergic disorders, especially niacin-induced flushing. In our study, a series of novel laropiprant derivatives (I-1–I-18) were synthesized and characterized by IR, 1H-NMR, 13C-NMR and HRMS spectrum.
Haiping Zhou   +4 more
openaire   +1 more source

[Anti-allergic properties of pipethiaden--a new preventive agent for migraine].

Ceskoslovenska farmacie, 1989
Pipethiadene, a prophylactic of vasomotoric headaches of the series of 4,9-dihydrothieno(2,3-c)-2-benzothiepine derivatives, shows a peripheralpharmacological profile of an antiallergic agent. The experiments in rats showed a high antianaphylactic effect of pipethiadene in the passive cutaneous anaphylaxis (PCA) test.
H, Frycová, J, Metys
openaire   +1 more source

Mast cell degranulation and its inhibition by an anti-allergic agent tranilast

Virchows Archiv B Cell Pathology, 1988
Degranulation of IgE-sensitized rat mast cells by antigen was studied quantitatively in vitro and in vivo by electron microscopy. The inhibition of this degranulation by an anti-allergic drug, N-(3,4-dimethoxycinnamoyl)anthranilic acid (Tranilast), was also examined both in vitro and in vivo.
openaire   +2 more sources

Procaine as an anti-allergic agent.

Federation proceedings, 2008
R H, DREISBACH, N, CHU
openaire   +1 more source

Home - About - Disclaimer - Privacy